Biosimilar Sponsors May Seek Interchangeability Before FDA Sets Rules
This article was originally published in The Pink Sheet Daily
Executive Summary
As with its approval of the first biosimilar product, FDA may also set precedent by making its first interchangeability determination before issuing guidance.
You may also be interested in...
Finally … Rachel Sherman Takes Califf's Old FDA Job
After months of speculation, FDA veteran Rachel Sherman becomes deputy commissioner for medical products and tobacco.
Sandoz's Multi-Switch Biosimilar Trials: A View To Interchangeability?
Company's application development seems to be outpacing FDA's policy development in next step along the 351(k) pathway.
Sandoz's Multi-Switch Biosimilar Trials: A View To Interchangeability?
Company's application development seems to be outpacing FDA's policy development in next step along the 351(k) pathway.